Yulia POLKOVNIKOVA, Kseniya KORYANOVA

Microcapsules made of sodium alginate for the prolonged release of phenibut

A prolonged system of the pharmaceutical substance delivery with nootropic effect was developed; it was phenibut in the form of microcapsules. The polymers used were sodium alginate as polyanion and Calcium chloride as polycation. It was realized by spraying a solution of sodium alginate in a solution of Calcium chloride, which induces the gelation. The features of the surface for the obtained microcapsules with the different ratio of nucleus/substance were determined in the work. Identification of phenibut in microcapsules was performed by IR-spectroscopy. Dependence of the microencapsulation efficiency on the concentration of film-forming material solution and the ratio of nucleus/substance was found. The process of phenibut release from microcapsules in the medium of 0.1 M solution of hydrochloric acid was investigated.

PDF

___

Hojjati M, Razavi SH, Rezaei K. Gilani K. Spray drying microencapsulation of natural canthaxantin using soluble soybean polysaccharide as a carrier. Food Sci Biotechnol. 2011; 20: 63-69. [CrossRef]
Fuensanta M, Grau A, Romero-Sánchez MD, Guillem C, López-Buendía MÁ. Effect of the polymer shell in imidazole microencapsulation by solvent evaporation method. Polym. Bull. 2013; 70: 3055-3074. [CrossRef]
Mano JF. Stimuli-responsive polymeric systems for biomedical applications. Adv Eng Mater. 2008; 10: 515–527. [CrossRef]
Goh CH, Heng PWS, Chan LW. Alginates as a useful natural polymer for microencapsulation and therapeutic applications. Carbohydr Polym. 2012; 88: 1–12. [CrossRef]
Xie J, Wang CH Electrospray in the dipping mode for cell microencapsulation. J Colloid Interface Sci. 2007; 312: 247– 255. [CrossRef]
Xu J, Li S, Tan J, Luo G. Controllable preparation of monodispersed calcium alginate microbeads in a novel microfluidic system. Chem Eng Technol. 2008; 31: 1223–1226. [CrossRef]
Zhong D, Huang X, Yang H, Cheng R. New insights into viscosity abnormality of sodium alginate aqueous solution. Carbohydr Polym. 2011; 81(4): 948–9. [CrossRef]
Chan ES, Wong SL, Lee PP, Lee JS, Ti TB, Zhang Z, Poncelet D, Ravindra P, Phan SH, Yim ZH. Effects of starch filler on the physical properties of lyophilized calcium–alginate beads and the viability of encapsulated cells. Carbohydr Polym. 2011; 83(1): 225–232. [CrossRef]
Agnihotri SA, Aminabhavi TM. Controlled release of clozapine through chitosan microparticles prepared by a novel method. Journal of Controlled Release. 2004; 96(2): 245–259. [CrossRef]
Li J, Zhang JJ, Zhao XJ. Preparation of porcine hemoglobin microcapsules of chitosan-sodium alginate. Frontiers of Chemistry in China. 2007; 2(3): 315–317. [CrossRef]
El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int J Pharm. 2002, 249(1–2): 7–21. [CrossRef]
Lin WC, Yu DG, Yang MC. pH-Sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties. Colloid Surface B: Biointerfaces. 2005; 44(2–3): 143–151. [CrossRef]
Wang CY, Ye SQ, Dai L, Liu XX, Tong Z. Enhanced resistance of polyelectrolyte multilayer microcapsules to pepsin erosion and release properties of encapsulated indomethacin. Biomacromolecules. 2007; 8: 1739–1744. [CrossRef]
Anal AK, Stevens WF, Remunan-lopez C. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int J Pharm. 2006; 312(1–2): 166–173. [CrossRef]
Om Prakash Ranjan, Gopal Venkatesh Shavi, Usha Yogendra Nayak, Karthik Arumugam, Ranjith Kumar Averineni, Sreenivasa Reddy Meka, Pandey Sureshwar. Controlled release chitosan microspheres of mirtazapine: In vitro and in vivo evaluation. Arch Pharm Res. 2011; 34(11): 1919-1929. [CrossRef]
Giordano C, Viscomi C, Orlandi M, Paola PapoffAlberto SpaliceAlberto BurlinaIvano Di MeoValeria TirantiVincenzo LeuzziGiulia d’Amati Massimo Zeviani. Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy. J Inherit Metab Dis. 2012; 35: 451-458. [CrossRef]
Crona DJ, Whang YE. Posterior reversible encephalopathy syndrome induced by enzalutamide in a patient with castration-resistant prostate cancer. Invest New Drugs. 2015; 33: 751-754. [CrossRef]
Rivera-Ingraham GA., Espinosa F, Krock B. Presence of Gamma-Aminobutyric Acid (Gaba) in the Pedal Mucus of the Critically Endangered Species Patella ferrugineaJ Chem Ecol. 2015; 41: 501-504. [CrossRef]
Yu HH, Choi JH, Kang KM. Potential of a lactic acid bacterial starter culture with gamma-aminobutyric acid (GABA) activity for production of fermented sausage. Food Sci Biotechnol. 2017; 26: 1333-1341. [CrossRef]
Polkovnikova YA, Glushko AA, Mikhailovskaya IY, Karieva YS. Simulation of vinpocetine release process from microcapsules with hydrophobic shell. Pharmacy & Pharmacology. 2017; 5(4): 344-367. [CrossRef]
Zavadenko NN, Suvorinova NY. Results of Pharmacotherapy of Attention Deficit Hyperactivity Disorder: Assessment Using Neuropsychological Methods. Neurosci Behav Physi. 2016; 46: 354-359. [CrossRef]